Nextage Therapeutics Ltd (NXTG.TA)

ILA 97.0

(-13.16%)

Total Liabilities Summary of Nextage Therapeutics Ltd

Nextage Therapeutics Ltd's latest annual total liabilities in 2023 was 3.83 Million ILS , up 97.73% from previous year.
Nextage Therapeutics Ltd's latest quarterly total liabilities in 2023 FY was 3.83 Million ILS , up 97.73% from previous quarter.
Nextage Therapeutics Ltd reported annual total liabilities of 1.93 Million ILS in 2022, down -48.4% from previous year.
Nextage Therapeutics Ltd reported annual total liabilities of 3.75 Million ILS in 2021, up 43.36% from previous year.
Nextage Therapeutics Ltd reported quarterly total liabilities of 3.83 Million ILS for 2023 FY, up 97.73% from previous quarter.
Nextage Therapeutics Ltd reported quarterly total liabilities of 2.36 Million ILS for 2023 Q2, up 21.88% from previous quarter.

Annual Total Liabilities Chart of Nextage Therapeutics Ltd (2023 - 2017)

Historical Annual Total Liabilities of Nextage Therapeutics Ltd (2023 - 2017)

Year	Total Liabilities	Total Liabilities Growth
2023	3.83 Million ILS	97.73%
2022	1.93 Million ILS	-48.4%
2021	3.75 Million ILS	43.36%
2020	2.62 Million ILS	11.49%
2019	2.35 Million ILS	-67.02%
2018	7.12 Million ILS	-10.46%
2017	7.95 Million ILS	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q4	3.83 Million ILS	62.24%
2023 FY	3.83 Million ILS	97.73%
2023 Q2	2.36 Million ILS	21.88%
2022 Q4	1.93 Million ILS	9.55%
2022 FY	1.93 Million ILS	-48.4%
2022 Q2	1.76 Million ILS	-52.9%
2021 Q4	3.75 Million ILS	17.6%
2021 Q2	3.19 Million ILS	21.91%
2021 FY	3.75 Million ILS	43.36%
2020 Q2	2.91 Million ILS	23.87%
2020 FY	2.62 Million ILS	11.49%
2020 Q4	2.62 Million ILS	-10.0%
2019 FY	2.35 Million ILS	-67.02%
2019 Q4	2.35 Million ILS	-65.07%
2019 Q2	6.72 Million ILS	-5.59%
2018 FY	7.12 Million ILS	-10.46%
2018 Q4	7.12 Million ILS	0.0%
2017 FY	7.95 Million ILS	0.0%

Peer Total Liabilities Comparison of Nextage Therapeutics Ltd

Name	Total Liabilities	Total Liabilities Difference
Cannabotech LTD	9.68 Million ILA	60.442%